eGFR Trajectory in LVAD Recipients with Right Heart Failure: Status Quo or a Steady Decline?
eGFR Trajectory in LVAD Recipients with Right Heart Failure: Status Quo or a Steady Decline?
复制标题
患有右心衰竭的 LVAD 接受者的 eGFR 轨迹:现状还是稳步下降?
DOI:
10.1161/jaha.124.033925
复制
发表时间:
2024
影响因子:
5.4
通讯作者:
Agdamag,ArianneC
中科院分区:
文献类型:
--
作者:
Roehm,Bethany;Agdamag,ArianneC
Two outcomes particularly dreaded after left ven-tricular assist device (LVAD) implantation are development of right heart failure (RHF) and worsening kidney function. Yet for better or worse, right heart function and kidney function are innately intertwined (Figure). Increased venous return, left ventricular (LV) unloading, changes in systemic afterload, intraoperative factors, the effects of chronic heart failure (HF) on right ventricular function, and conformational changes in how ventricles twist as a result of LVAD being sewn into LV can all contribute to the development of postoperative RHF. 1 Chronic kidney disease itself may contribute to the development of RHF via reduced glomerular filtration rate (GFR), tubular dysfunction, renin-angiotensin-aldosterone system activation, and possibly other mechanisms such as uremic toxin build-up and higher FGF-23 levels. 2–5 RHF may adversely affect kidney function predominantly through elevated systemic venous pressure, which leads to a cascade of downstream effects all culminating in reduced GFR and reduced diuretic efficiency, with cardiac underfilling likely playing a more minor role. 6, 7